Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1993;1(3):153–161. doi: 10.1155/S1064744993000341

Review of Vaginitis

Sebastian Faro 1,✉
PMCID: PMC2364310  PMID: 18475337

Abstract

Adisruption of the dynamic equilibrium of the healthy vagina may have significant sequelae, leading to chronic or serious conditions. Therefore, all cases of vaginitis should be accurately diagnosed and appropriately treated.

Full Text

The Full Text of this article is available as a PDF (825.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson R. E., Daeschel M. A., Hassan H. M. Antibacterial activity of plantaricin SIK-83, a bacteriocin produced by Lactobacillus plantarum. Biochimie. 1988 Mar;70(3):381–390. doi: 10.1016/0300-9084(88)90211-8. [DOI] [PubMed] [Google Scholar]
  2. Barefoot S. F., Klaenhammer T. R. Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol. 1983 Jun;45(6):1808–1815. doi: 10.1128/aem.45.6.1808-1815.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beard C. M., Noller K. L., O'Fallon W. M., Kurland L. T., Dockerty M. B. Lack of evidence for cancer due to use of metronidazole. N Engl J Med. 1979 Sep 6;301(10):519–522. doi: 10.1056/NEJM197909063011003. [DOI] [PubMed] [Google Scholar]
  4. Cooke C. W. Vulvovaginal candidiasis. Obstet Gynecol. 1976 Nov;48(5):631–632. [PubMed] [Google Scholar]
  5. Cox S. M., Phillips L. E., Mercer L. J., Stager C. E., Waller S., Faro S. Lactobacillemia of amniotic fluid origin. Obstet Gynecol. 1986 Jul;68(1):134–135. [PubMed] [Google Scholar]
  6. Dahiya R. S., Speck M. L. Hydrogen peroxide formation by lactobacilli and its effect on Staphylococcus aureus. J Dairy Sci. 1968 Oct;51(10):1568–1572. doi: 10.3168/jds.S0022-0302(68)87232-7. [DOI] [PubMed] [Google Scholar]
  7. Echeverria P., Blacklow N. R., Sanford L. B., Cukor G. G. Travelers' diarrhea among American Peace Corps volunteers in rural Thailand. J Infect Dis. 1981 Jun;143(6):767–771. doi: 10.1093/infdis/143.6.767. [DOI] [PubMed] [Google Scholar]
  8. Erickson S. H., Oppenheim G. L., Smith G. H. Metronidazole in breast milk. Obstet Gynecol. 1981 Jan;57(1):48–50. [PubMed] [Google Scholar]
  9. Eschenbach D. A., Davick P. R., Williams B. L., Klebanoff S. J., Young-Smith K., Critchlow C. M., Holmes K. K. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol. 1989 Feb;27(2):251–256. doi: 10.1128/jcm.27.2.251-256.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Faro S., Phillips L. E. Non-specific vaginitis or vaginitis of undetermined aetiology. Int J Tissue React. 1987;9(2):173–177. [PubMed] [Google Scholar]
  11. Friedman G. D. Cancer after metronidazole. N Engl J Med. 1980 Feb 28;302(9):519–519. doi: 10.1056/NEJM198002283020911. [DOI] [PubMed] [Google Scholar]
  12. Friedrich E. G., Jr Therapeutic studies on vulvar vestibulitis. J Reprod Med. 1988 Jun;33(6):514–518. [PubMed] [Google Scholar]
  13. Friedrich E. G., Jr Vulvar vestibulitis syndrome. J Reprod Med. 1987 Feb;32(2):110–114. [PubMed] [Google Scholar]
  14. Frytak S., Moertel C. H., Childs D. S. Neurologic toxicity associated with high-dose metronidazole therapy. Ann Intern Med. 1978 Mar;88(3):361–362. doi: 10.7326/0003-4819-88-3-361. [DOI] [PubMed] [Google Scholar]
  15. GARDNER H. L., DUKES C. D. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955 May;69(5):962–976. [PubMed] [Google Scholar]
  16. Greaves W. L., Chungafung J., Morris B., Haile A., Townsend J. L. Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol. 1988 Nov;72(5):799–802. [PubMed] [Google Scholar]
  17. Hager W. D., Brown S. T., Kraus S. J., Kleris G. S., Perkins G. J., Henderson M. Metronidazole for vaginal trichomoniasis. Seven-day vs single-dose regimens. JAMA. 1980 Sep 12;244(11):1219–1220. [PubMed] [Google Scholar]
  18. Horowitz B. J., Edelstein S. W., Lippman L. Sexual transmission of Candida. Obstet Gynecol. 1987 Jun;69(6):883–886. [PubMed] [Google Scholar]
  19. Klebanoff S. J., Smith D. C. Peroxidase-mediated antimicrobial activity of rat uterine fluid. Gynecol Invest. 1970;1(1):21–30. doi: 10.1159/000301903. [DOI] [PubMed] [Google Scholar]
  20. Lee L., Schmale J. D. Ampicillin therapy for Corynebacterium vaginale (Haemophilus vaginalis) vaginitis. Am J Obstet Gynecol. 1973 Mar 15;115(6):786–788. doi: 10.1016/0002-9378(73)90521-8. [DOI] [PubMed] [Google Scholar]
  21. Lossick J. G., Müller M., Gorrell T. E. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis. 1986 May;153(5):948–955. doi: 10.1093/infdis/153.5.948. [DOI] [PubMed] [Google Scholar]
  22. Meingassner J. G., Thurner J. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother. 1979 Feb;15(2):254–257. doi: 10.1128/aac.15.2.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miles M. R., Olsen L., Rogers A. Recurrent vaginal candidiasis. Importance of an intestinal reservoir. JAMA. 1977 Oct 24;238(17):1836–1837. doi: 10.1001/jama.238.17.1836. [DOI] [PubMed] [Google Scholar]
  24. Müller M., Lossick J. G., Gorrell T. E. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex Transm Dis. 1988 Jan-Mar;15(1):17–24. doi: 10.1097/00007435-198801000-00004. [DOI] [PubMed] [Google Scholar]
  25. PEREYRA A. J., LANSING J. D. UROGENITAL TRICHOMONIASIS; TREATMENT WITH METRONIDAZOLE IN 2002 INCARCERATED WOMEN. Obstet Gynecol. 1964 Oct;24:499–508. [PubMed] [Google Scholar]
  26. Pyka R. E., Wilkinson E. J., Friedrich E. G., Jr, Croker B. P. The histopathology of vulvar vestibulitis syndrome. Int J Gynecol Pathol. 1988;7(3):249–257. doi: 10.1097/00004347-198809000-00005. [DOI] [PubMed] [Google Scholar]
  27. Redondo-Lopez V., Lynch M., Schmitt C., Cook R., Sobel J. D. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol. 1990 Oct;76(4):651–655. [PubMed] [Google Scholar]
  28. Reid G., Cook R. L., Bruce A. W. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol. 1987 Aug;138(2):330–335. doi: 10.1016/s0022-5347(17)43137-5. [DOI] [PubMed] [Google Scholar]
  29. Schnell J. D. The incidence of vaginal candida and trichomonas infections and treatment of trichomonas vaginitis with clotrimazole. Postgrad Med J. 1974 Jul;50 (Suppl 1):79–81. [PubMed] [Google Scholar]
  30. Sobel J. D. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985 Aug 1;152(7 Pt 2):924–935. doi: 10.1016/s0002-9378(85)80003-x. [DOI] [PubMed] [Google Scholar]
  31. Therapy of candidal vaginitis: the effect of eliminating intestinal Candida. Nystatin Multicenter Study Group. Am J Obstet Gynecol. 1986 Sep;155(3):651–655. doi: 10.1016/0002-9378(86)90297-8. [DOI] [PubMed] [Google Scholar]
  32. Turner M. L., Marinoff S. C. Association of human papillomavirus with vulvodynia and the vulvar vestibulitis syndrome. J Reprod Med. 1988 Jun;33(6):533–537. [PubMed] [Google Scholar]
  33. Upreti G. C., Hinsdill R. D. Isolation and characterization of a bacteriocin from a homofermentative Lactobacillus. Antimicrob Agents Chemother. 1973 Oct;4(4):487–494. doi: 10.1128/aac.4.4.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Woodruff J. D., Friedrich E. G., Jr The vestibule. Clin Obstet Gynecol. 1985 Mar;28(1):134–141. doi: 10.1097/00003081-198528010-00016. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES